Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Melanoma/Skin Cancer
Would you ever consider SBRT for de novo cutaneous squamous cell carcinoma?
Is there any data to support it? What dose/fractionation would you consider?
Answer from: Radiation Oncologist at Community Practice
No role for SBRT.
Sign In
or
Register
to read more
12444
Related Questions
How would you manage a scalp squamous cell carcinoma s/p Mohs with high risk features who underwent placental grafting to expedite the healing process?
For a cutaneous malignancy near the eyelid, how do you decide whether to use an internal eye shield or an external eye shield during treatment?
How do you treat a large basal cell carcinoma involving the dorsum and entire tip of the nose when brachytherapy and orthovoltage are not feasible?
If adjuvant radiation is indicated for a Merkel cell carcinoma of the upper extremity and hypofractionation is desired, what dosing regimens are recommended?
How would you manage BCC to the left cheek after only half of a radiation course was completed three months ago and non-operative management is preferred?
How would you treat a basal cell carcinoma on the temporal skin and zygomatic area s/p excision with PNI and significant flaps for closure?
Would you include the internal mammary nodes (unilateral or bilateral) in the adjuvant radiation field for a small Merkel cell carcinoma located along the sternum on the medial chest wall, s/p R0 resection, but no sentinel lymph node biopsy?
Would you consider neoadjuvant immunotherapy prior to radiation for a locally advanced skin squamous cell carcinoma?
How would you approach the radiation treatment of multiple recurrent lentigo maligna on the sole of the foot in an active patient not desiring further surgery?
In what situations would you recommend adjuvant radiation therapy for patients with locally advanced and/or recurrent basal cell carcinoma that receive vismodegib followed by surgery?